FDA-Inspected Site

Actavis Pharma Development Centre Private Limited

4 FDA inspections are on record for Actavis Pharma Development Centre Private Limited in Chennai, India.

483· Form 483 issued

Chennai, India · Last updated July 9, 2026

Overview

  • 4 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2023-07-11.

At a glance

Inspections

4

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Jul 2023 – 11 Jul 2023Human Drugs483On file
18 Sep 2017 – 21 Sep 2017Human Drugs483On file
3 Dec 2014 – 5 Dec 2014Human DrugsClean
20 Oct 2011Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

11 Jul 2023
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Guerlain Ulysse

11 Jul 2023
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Guerlain Ulysse

11 Jul 2023
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Guerlain Ulysse

21 Sep 2017
21 CFR 211.166(a)(3)

Valid stability test methods

Cited by Linda F Murphy

21 Sep 2017
21 CFR 211.194(b)

Test method modification records do not include

Cited by Linda F Murphy

Investigators

FDA investigators tied to this site in the record.

Larry K Austin1 insp.
Mural B Gavini1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites